Clinical Trial

Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma

Name: Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma — clinical trial record (NCT07747935)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Uveal Melanoma

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Neoadjuvant RBP-01 in patients with primary uveal melanoma.

Trial Details

NCT Number	NCT07747935
Lead Sponsor	ReBio Pharma
Conditions	Uveal Melanoma
Enrollment	30 participants
Start Date	2026-10-01
Primary Completion	2028-04-01 (estimated)
Study Completion	2028-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-05